Skip to main content
Premium Trial:

Request an Annual Quote

Foundation Medicine: Dymeka Harrison

Foundation Medicine has appointed Dymeka Harrison as chief commercial officer, where she will develop and execute global clinical commercial strategy and strengthen customer relationships, as well as establish new partnerships. She most recently served as VP of global strategic marketing at Abbott, overseeing global marketing efforts for the firm's rapid diagnostics division. Harrison also worked at Qiagen as VP of sales for its QuantiFeron and AmniSure businesses and was a national sales manager in the clinical division at BioMérieux. She has also served as a sales director at Thermo Fisher Scientific.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.